EnCor EnCompass™ Breast Biopsy and Tissue Removal System
K-Number: K262571 · 2026-08-14
Device Summary
Frequently Asked Questions
What is the EnCor EnCompass™ Breast Biopsy and Tissue Removal System?
EnCor EnCompass™ Breast Biopsy and Tissue Removal System is a medical device that received FDA 510(k) clearance on 2026-08-14. The listed applicant is Bard Peripheral Vascular, Inc.. The 510(k) number is K262571.
When did EnCor EnCompass™ Breast Biopsy and Tissue Removal System receive FDA 510(k) clearance?
EnCor EnCompass™ Breast Biopsy and Tissue Removal System received FDA 510(k) clearance on 2026-08-14, under 510(k) number K262571.
Who is the listed applicant for EnCor EnCompass™ Breast Biopsy and Tissue Removal System?
The FDA 510(k) record lists Bard Peripheral Vascular, Inc. as the applicant. This does not by itself establish the device manufacturer.
What is the FDA product code for EnCor EnCompass™ Breast Biopsy and Tissue Removal System?
The FDA product code for EnCor EnCompass™ Breast Biopsy and Tissue Removal System is KNW.
Related Clinical Trials
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Other records listing Bard Peripheral Vascular, Inc. as applicant
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Related Devices (Code: KNW)
Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.